Press Releases for the Psychedelics Industry | Page 35 of 37

Psychedelics News

Press Releases

5 Nov 2020

COMPASS Pathways plc to announce third quarter 2020 financial results on 12 November 2020

London, UK, Nov....

By Microdose

Press Releases

4 Nov 2020

COMPASS Pathways plc to participate in Berenberg and Evercore investor conferences

London, UK, Nov....

By Microdose

Press Releases

30 Oct 2020

MindMed Closes Upsized Financing of CAD $28.75m With Strong Institutional Demand for Psychedelic Medicines

Post-Financing Cash Reserves of CAD $50....

By Microdose

Press Releases

28 Oct 2020

MPV announces CSE’s conditional approval of its transaction with Entheon Biomedical Corp.

MONTREAL, Oct....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

26 Oct 2020

Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19

By Microdose

Press Releases

26 Oct 2020

COMPASS Pathways plc to ring Nasdaq Stock Exchange opening bell in celebration of its successful $146.6 million IPO

COMPASS Pathways plc to ring Nasdaq Stock Exchange opening bell in celebration of its successful $146....

By Microdose

Press Releases

20 Oct 2020

Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds

Expanding research and development of naturally-derived psilocybin for future FDA IND-enabling and clinical studies TORONTO, Oct....

By Microdose

Press Releases

16 Oct 2020

MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Oct....

By Microdose

Press Releases

8 Oct 2020

MindMed Announces $25 Million Bought Deal Public Offering

NEW YORK, Oct....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result